WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher HiteChair;EVP2026-08-18100,000$59.97
$6.00MSell
Terrance P. CoyneCFO;EVP2026-08-139,230$58.59
$540.75kSell
Terrance P. CoyneCFO;EVP2026-08-131,772$59.14
$104.80kSell
Marshall UristEVP Research Investments2026-07-019,099$55.88
$508.45kSell
Christopher HiteEVP Chairman Partnering2026-06-302,554$57.10
$145.84kSell
Christopher HiteEVP Chairman Partnering2026-06-3029,400$56.44
$1.66MSell
Bonnie L. BasslerDirector2026-06-30689$54.40
$37.48kBuy
Christopher HiteEVP Chairman Partnering2026-06-3097,446$56.50
$5.51MSell
Christopher HiteEVP Chairman Partnering2026-06-30600$57.09
$34.25kSell
Marshall UristEVP Research Investments2026-06-249,098$55.18
$502.06kSell

1 of 8

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC6.73%38,714,280$2.48BInsider
1978 Sicaf Sif Sa 1. Gg3.84%22,081,156$1.41BInsider
1978 Sicaf Sif Sa Gg3.73%21,426,170$1.37BInsider
Pablo G. Legorreta1.48%8,526,570$545.36MInsider
William E. Ford0.71%4,086,134$261.35MInsider
Mario Germano Giuliani0.61%3,535,267$226.12MInsider
Rory B. Riggs0.27%1,533,296$98.07MInsider
Christopher Hite0.15%853,000$54.56MInsider
James F. Reddoch0.15%845,830$54.10MInsider
George W. Lloyd0.14%779,915$49.88MInsider

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX0.06%18.01%Net SellingNet Selling
ALNY0.10%20.79%Net Selling
ROIV0.08%92.24%Net SellingNet Selling
ONC0.00%30.90%Net SellingNet Selling
INSM0.10%17.37%Net SellingNet Selling
View Top Biotech Stocks

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 0.06% institutional shareholders, 18.01% Royalty Pharma insiders, and 81.93% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.73% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $2.35B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.